[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Instituto Médico Tecnológico SL\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":50},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100570650","effectiveness-of-a-telerehabilitation-program-for-improving-sexual-function-and-reducing-pain-in-menopausal-women-100570650",false,"NCT06710002","Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women","Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women With Dyspareunia: Protocol of a Randomized Clinical Trial.","Inclusion Criteria:\n\n* Female\n* Age from 45 to 65 years.\n* Menopausal\n* Suffer dyspareunia for 3 months of evolution.\n* Willing to complete study questionnaires and informed consent study.\n\nExclusion Criteria:\n\n* Pacemaker or other types of electronic implant.\n* Thrombophlebitis.\n* Skin hypersensitivity or rejection of manual contact.\n* Active or previous treatment with chemotherapy or radiotherapy in the pelvic area.\n* Wounds or burns in the pelvic area.\n* Allergy to nickel and chromium.\n* Other pelvic floor physiotherapy treatments during the study intervention.\n* Other medical and surgical treatments in the pelvic region, such as muscle infiltrations or nerve blocks during the study intervention.\n* Surgical intervention in the pelvic area in the last 3 months.\n* Fibromyalgia.\n* Oncological processes that affect the sacrum.\n* Systemic diseases (infectious, vascular, endocrine, metabolic or neoplastic conditions).\n* Neuromuscular diseases (Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Myasthenia Gravis or spinal muscular atrophy).\n* Myelopathy and Osteomyelitis.\n* Diseases that cause alterations of the central nervous system (traumatic or vascular spinal cord injury).\n* Neurological or metabolic conditions that affect the ability to respond (Diabetes, Parkinson's disease, senile dementia, etc).\n* Serious mental disorder.","FEMALE","45 Years","65 Years",{"count":20,"type":21},90,"ESTIMATED","INTERVENTIONAL",[24],"NA","The aim of this study is to analyze the effectiveness of a telerehabilitation program with respect to a face-to-face physiotherapy protocol in relation to the improvement of sexual function, the reduction of pain and the improvement of the quality of life, in the treatment of menopausal women with dyspareunia.",[27,28,29],"Menopause","Genitourinary Syndrome of Menopause","Dyspareunia",[31,32,33,34,35,36,37],"Physiotherapy","Telerehabilitation","face to face treatment","female sexual function","vaginal dilators","manual therapy","capacitive resistive monopolar radiofrequency","RECRUITING","2025-05-20",{"date":41,"type":42},"2025-05-23","ACTUAL",{"date":44,"type":42},"2025-05-05",{"date":46,"type":21},"2026-03",{"name":48,"class":49},"Instituto Médico Tecnológico SL","OTHER",""]